|
Real-time
Euronext Paris
10:30:11 2019-10-23 am EDT
|
5-day change | 1st Jan Change | ||
| 20.20 EUR | -.--% |
|
-.--% | +18.82% |
| Market Cap | 38.47M 33.15M 31.08M 28.37M 53.45M 3.68B 53.62M 369M 144M 1.86B 144M 141M 6.15B | P/E 2017 |
17.4x | P/E 2018 | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 36.72M 31.64M 29.66M 27.08M 51.01M 3.51B 51.17M 352M 137M 1.77B 138M 135M 5.87B | EV / Sales 2017 |
1.97x | EV / Sales 2018 | 1.38x |
| Free-Float |
5.42% | Yield 2017 |
3.36% | Yield 2018 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Millet
CEO | Chief Executive Officer | - | 2002-12-08 |
Valérie Chopinet
DFI | Director of Finance/CFO | - | 2006-12-18 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 1998-03-15 | |
Pierre Martin
BRD | Director/Board Member | - | 1998-03-15 |
| Director/Board Member | - | 2011-03-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 42.79M | ||
| +7.58% | +4.88% | +4.60% | -26.76% | 6.56B | ||
| +1.55% | +1.12% | +2.13% | +24.06% | 1.35B | ||
| +0.88% | -0.04% | +19.54% | +35.79% | 591M | ||
| -0.04% | -2.19% | -11.09% | +29.20% | 67.96M | ||
| Average | +1.98% | +1.51% | +3.79% | +15.57% | 1.72B | |
| Weighted average by Cap. | +6.03% | +6.70% | +5.11% | -13.98% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 21.86M 18.84M 17.66M 16.12M 30.37M 2.09B 30.47M 210M 81.75M 1.05B 82.07M 80.28M 3.5B | 22.21M 19.14M 17.94M 16.38M 30.86M 2.12B 30.96M 213M 83.06M 1.07B 83.39M 81.57M 3.55B |
| Net income | 2.54M 2.19M 2.05M 1.88M 3.53M 243M 3.54M 24.37M 9.51M 123M 9.55M 9.34M 407M | 1.63M 1.41M 1.32M 1.2M 2.27M 156M 2.28M 15.65M 6.11M 78.76M 6.13M 6M 261M |
| Net Debt | -1.07M -918K -861K -786K -1.48M -102M -1.49M -10.21M -3.99M -51.41M -4M -3.91M -170M | -1.75M -1.51M -1.42M -1.29M -2.43M -167M -2.44M -16.8M -6.55M -84.54M -6.58M -6.44M -280M |
Employees
-
Sector
Drug Retailers
- Stock Market
- Stocks
- ALINN Stock
Select your edition
All financial news and data tailored to specific country editions
















